financetom
Business
financetom
/
Business
/
Atlassian Insider Sold Shares Worth $1,819,203, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atlassian Insider Sold Shares Worth $1,819,203, According to a Recent SEC Filing
Mar 21, 2025 12:59 AM

03:43 AM EDT, 03/21/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Chief Executive Officer, Co-Founder, on March 19, 2025, sold 7,948 shares in Atlassian ( TEAM ) for $1,819,203. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 63,584 Class A common shares of the company, with 63,584 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1650372/000156218025002643/xslF345X05/primarydocument.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Visa Stock Today?
What's Going On With Visa Stock Today?
Mar 11, 2025
Visa Inc. ( V ) shares are trading lower on Tuesday. The banking behemoth has launched a new initiative aimed at tackling complex scams and preventing massive financial losses. The company’s newly formalized scam disruption practice, under its Visa Payment Ecosystem Risk and Control division, prevented over $350 million in attempted fraud in 2024 alone. This achievement is in addition...
Fokus Mining Says Hendrick Deposit Drilling Shows Gold and Copper Mineralization
Fokus Mining Says Hendrick Deposit Drilling Shows Gold and Copper Mineralization
Mar 11, 2025
12:38 PM EDT, 03/11/2025 (MT Newswires) -- Fokus Mining ( FKMCF ) Tuesday said exploration drilling at the Hendrick Deposit on its Galloway Property in Quebec showed gold and copper mineralization. The company best results included 1.7 grams per tonne of gold over 24 meters and 2.05 gold-equivalent gpt over 21.6 meters. Our latest drilling results are encouraging, we have...
Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial
Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial
Mar 11, 2025
Arvinas, Inc. ( ARVN ) and Pfizer Inc ( PFE ). released topline results from the Phase 3 VERITAC-2 trial evaluating vepdegestrant monotherapy versus fulvestrant in adult patients with advanced or metastatic breast cancer. The results of the trial, released Monday, included estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer patients whose disease progressed following prior...
Visa, Mastercard Unlikely to Yield Market Dominance Anytime Soon, UBS Says
Visa, Mastercard Unlikely to Yield Market Dominance Anytime Soon, UBS Says
Mar 11, 2025
12:31 PM EDT, 03/11/2025 (MT Newswires) -- Visa (V) and Mastercard ( MA ) continue to offer investors with a ready path to the broader payments and fintech sector, analysts at UBS said in a new research note on Tuesday. The credit card issuers provide a balanced exposure to traditional consumer spending as well as new payment methods, showing persistent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved